126 related articles for article (PubMed ID: 11979338)
1. Quantitative analyses of osteopontin mRNA expression in human proximal tubules isolated from renal biopsy tissue sections of minimal change nephrotic syndrome and IgA glomerulonephropathy patients.
Kaimori JY; Takenaka M; Nagasawa Y; Nakajima H; Izumi M; Akagi Y; Imai E; Hori M
Am J Kidney Dis; 2002 May; 39(5):948-57. PubMed ID: 11979338
[TBL] [Abstract][Full Text] [Related]
2. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy.
Gang X; Ueki K; Kon S; Maeda M; Naruse T; Nojima Y
Am J Kidney Dis; 2001 Feb; 37(2):374-9. PubMed ID: 11157380
[TBL] [Abstract][Full Text] [Related]
3. Tubular osteopontin expression in patients with ANCA-associated glomerulonephritis.
Nitta K; Horita S; Okano K; Uchida K; Honda K; Koike M; Sekine S; Itabashi M; Tsukada M; Takei T; Suzuki K; Yumura W; Nihei H
Clin Nephrol; 2001 Dec; 56(6):459-66. PubMed ID: 11770797
[TBL] [Abstract][Full Text] [Related]
4. Tubular osteopontin expression in human glomerulonephritis and renal vasculitis.
Okada H; Moriwaki K; Konishi K; Kobayashi T; Sugahara S; Nakamoto H; Saruta T; Suzuki H
Am J Kidney Dis; 2000 Sep; 36(3):498-506. PubMed ID: 10977781
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
Lopez CA; Hoyer JR; Wilson PD; Waterhouse P; Denhardt DT
Lab Invest; 1993 Sep; 69(3):355-63. PubMed ID: 8377476
[TBL] [Abstract][Full Text] [Related]
6. Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies.
Drakopoulos A; Goumenos DS; Vlachojannis JG; Tsakas S
Ren Fail; 2006; 28(6):461-7. PubMed ID: 16928614
[TBL] [Abstract][Full Text] [Related]
7. Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndrome.
Fujigaki Y; Tamura Y; Nagura M; Arai S; Ota T; Shibata S; Kondo F; Yamaguchi Y; Uchida S
BMC Nephrol; 2017 Nov; 18(1):339. PubMed ID: 29179690
[TBL] [Abstract][Full Text] [Related]
8. [Clinico-pathological evaluation of mesangial IgA deposition of minimal change with nephrotic syndrome].
Hamaguchi K; Tuchida H; Suzuki S; Miura Y; Nakazawa R; Suhara Y; Mimura N
Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1071-7. PubMed ID: 2287099
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
[TBL] [Abstract][Full Text] [Related]
10. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
[TBL] [Abstract][Full Text] [Related]
11. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
12. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.
Jinde K; Nikolic-Paterson DJ; Huang XR; Sakai H; Kurokawa K; Atkins RC; Lan HY
Am J Kidney Dis; 2001 Oct; 38(4):761-9. PubMed ID: 11576879
[TBL] [Abstract][Full Text] [Related]
13. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis.
Imakiire T; Kikuchi Y; Yamada M; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Oda T; Suzuki S; Miura S
Hypertens Res; 2007 Jul; 30(7):635-42. PubMed ID: 17785932
[TBL] [Abstract][Full Text] [Related]
14. [Angiotensin II up-regulates osteopontin mRNA expression of RAW264.7 macrophages via p38MAPK signaling].
Lou N; Yu XQ; Zhu SL; Zheng XH; Dong XQ; Li XY
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1283-7. PubMed ID: 15387967
[TBL] [Abstract][Full Text] [Related]
15. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
Yu XQ; Nikolic-Paterson DJ; Mu W; Giachelli CM; Atkins RC; Johnson RJ; Lan HY
Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083
[TBL] [Abstract][Full Text] [Related]
16. Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
Ashizawa M; Miyazaki M; Abe K; Furusu A; Isomoto H; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Kidney Dis; 2003 Jul; 42(1):76-86. PubMed ID: 12830459
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma.
Terashi T; Aishima S; Taguchi K; Asayama Y; Sugimachi K; Matsuura S; Shimada M; Maehara S; Maehara Y; Tsuneyoshi M
Liver Int; 2004 Feb; 24(1):38-45. PubMed ID: 15101999
[TBL] [Abstract][Full Text] [Related]
18. Expression of osteopontin in human glioma. Its correlation with the malignancy.
Saitoh Y; Kuratsu J; Takeshima H; Yamamoto S; Ushio Y
Lab Invest; 1995 Jan; 72(1):55-63. PubMed ID: 7837791
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus and cyclosporinein vitro and in vivo induce osteopontin mRNA and protein expression in renal tissues.
Khanna A
Nephron Exp Nephrol; 2005; 101(4):e119-26. PubMed ID: 16103732
[TBL] [Abstract][Full Text] [Related]
20. Age and development-related changes in osteopontin and nitric oxide synthase mRNA levels in human kidney proximal tubule epithelial cells: contrasting responses to hypoxia and reoxygenation.
Hwang SM; Wilson PD; Laskin JD; Denhardt DT
J Cell Physiol; 1994 Jul; 160(1):61-8. PubMed ID: 7517407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
